Eurospital focuses its activities in the in vitro diagnosis of Coeliac Disease and IBD, detection of genetic predisposition to Type 1 Diabetes and Lactose Intolerance. Actively present worldwide, Eurospital provides Pediatricians, Gastroenterologists and Laboratory Immunologists with highly innovative products, such as Calprest, CalFast, Eu-tTG, XeliGen and the newly available DiabeGen and LactoGen kits.
Included in Export Interest Directory? No
Business Needs: Direct Sales